CJJD [CHINA JO-JO DRUGSTORES] 8-K: (Original Filing)

[China Jo-Jo Drugstores Announces Fourth Quarter and Year End Financial Results for Fiscal Year 2017 -- FY 2017 Retail Pharmacy Sales increased by 1.1%; Gross Margin Increased From 19.7% to 20.4%; 9 New Pharmacies Added in 2017 (net) HANGZHOU, China, June 29, 2017 /PRNewswire/ -- China Jo-Jo Drugstor]

CJJD [CHINA JO-JO DRUGSTORES] 8-K: China Jo-Jo Drugstores Announces Fourth Quarter and Year

[China Jo-Jo Drugstores Announces Fourth Quarter and Year End Financial Results for Fiscal Year 2017 -- FY 2017 Retail Pharmacy Sales increased by 1.1%; Gross Margin Increased From 19.7% to 20.4%; 9 New Pharmacies Added in 2017 (net) HANGZHOU, China, June 29, 2017 /PRNewswire/ -- China Jo-Jo Drugstor]

AMCN [AIRMEDIA] 6-K: (Original Filing)

[AirMedia Files Its Annual Report on Form 20-F http://ir.airmedia.net.cn . The Company will provide a hard copy of its annual report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to IR Department]

By | 2017-06-29T14:27:26+00:00 June 29th, 2017|Categories: AMCN, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BIDU [Baidu] 424B2: (Original Filing)

[Prospectus Supplement (To Prospectus dated June 26, 2017) US$1,500,000,000 Baidu, Inc. US$900,000,000 2.875% Notes due 2022 US$600,000,000 3.625% Notes due 2027 We are offering US$900,000,000 of our 2.875% notes due 2022 (the “2022 Notes”) and US$600,000,000 of our 3.625% notes due 2027 (the “2027 N]

BIDU [Baidu] 424B2: Prospectus Supplement (To Prospectus dated June 26, 2017)

[Prospectus Supplement (To Prospectus dated June 26, 2017) US$1,500,000,000 Baidu, Inc. US$900,000,000 2.875% Notes due 2022 US$600,000,000 3.625% Notes due 2027 We are offering US$900,000,000 of our 2.875% notes due 2022 (the “2022 Notes”) and US$600,000,000 of our 3.625% notes due 2027 (the “2027 N]

BIDU [Baidu] 6-K: (Original Filing)

[Baidu Announces Pricing of US$1.5 Billion Notes Offering The Company expects to receive net proceeds from the offering of approximately US$1.49 billion, after deducting underwriting discounts and commissions and estimated offering expenses. The Company intends to use the net proceeds from the offeri]

Skip to toolbar